| 摘要 |
This invention relates to agents or compounds capable of interfering with th e binding of protein tyrosine phosphatase PEST to protein domains of signallin g molecules involved in cell migration, focal adhesion and/or cell proliferation, namely p130cas and paxillin. The agents can be derived from t he minimal sequences found in binding studies. PTP-PEST is a conserved phosphatase essential for embryo development. Knock-out cells (PTP-PEST -/-) have been perpetuated from null embryos and they show defects in cell migration, focal adhesion and cell proliferation. Therefore, any agent capab le of interfering with the activity of PEST in a diseased target tissue, is considered to be a potential therapeutic agent to treat any disease having a ny of the following etiological components: cell proliferation, cancer, metastasis, inflammation, and angiogenesis. This invention further relates t o a method for finding genuine substrates for enzymes, namely phosphatases, combining gene targetting knock-out technique and substrate-trapping techniq ue with the aid of a substrate binding inactive mutant enzyme. By using a gene targetting knock-out technique, there are less artefacts than by using other techniques (using vanadate compounds, for example) wherein an artificial non - specific increase of the level ofhyperphosphorylation occurs.
|
